2022

Report: Premium cigar ingredients as harmful as cigars and cigarettes


Dr. Steven Teutsch led a National Academies of Sciences, Engineering, and Medicine team investigating the health effects of "premium" cigars.

Two scientists in laboratory

The ingredients in premium cigars make them inherently as harmful as cigarettes and other types of cigars, says a new report from the National Academies of Sciences, Engineering, and Medicine. Because the majority of premium cigar smokers are nondaily or occasional users, and because they are less likely to inhale the smoke, the population health effects are currently modest.

Premium Cigars: Patterns of Use, Marketing, and Health Effects contains 13 conclusions related to health risks, addiction potential, and secondhand smoke exposure associated with premium cigars. It also provides recommendations to inform federal research on premium cigars, said Dr. Steven Teutsch, UCLA Fielding School of Public Health professor of health policy and management and chair of the National Academies, or NASEM, committee that wrote the report. The work was requested by the U.S. Food and Drug Administration (FDA) and National Institutes of Health (NIH). 

"Currently, about 1% of the U.S. adult population smoke premium cigars, and this percentage has remained stable over time," said Teutsch, who also serves as a faculty affiliate with the UCLA Fielding School's UCLA Center for Health Advancement. "The aim of this report is to provide FDA with the best available scientific information and to identify priorities for federally funded research on premium cigars."

No single characteristic differentiates premium cigars from other cigars, says the report. To guide its work, the committee that wrote the report defined a premium cigar as having all of the following six characteristics: handmade, composed of at least 50 percent natural long-leaf filler tobacco, wrapped in whole leaf tobacco, weighs at least 6 pounds per 1,000 units, has no filters or tips, and has no characterizing flavor other than tobacco. While the committee provided a working definition of premium cigars, it was not charged with recommending a regulatory definition or whether the FDA should regulate premium cigars.

The toxicants and carcinogens in premium cigar smoke are nearly identical to those in cigarette smoke, and they are capable of causing heart disease, cancers (lung, oral, head, and neck), respiratory diseases, and other adverse health effects, the report concludes. One’s actual health risks from smoking premium cigars, though, will be determined by smoking behavior — including frequency of use, the pattern and duration of smoking, and how deeply the smoke is inhaled. These conclusions are based on epidemiologic studies of cigars in general and biological mechanisms, as no currently available studies distinguish premium from other cigar types.

Premium cigar smokers are overwhelmingly male, older, white, and with higher income and education levels, and use is extremely rare among youth. However, the report concludes, should flavorings be added to premium cigars, it could result in increased popularity of the product, greater appeal to nonusers, and more frequent use — leading to increased nicotine intake, addiction potential, and exposure to harmful and potentially harmful chemicals.

Due to lack of data, there is insufficient evidence to determine if secondhand exposure to premium cigar smoke specifically is associated with health risks, the report concludes. There is plausible concern that people with underlying heart disease could be particularly vulnerable to secondhand premium cigar smoke. The location where premium cigars are used is a consideration with determining secondhand exposure risks (for example, outdoors versus indoors).

“One of the biggest research challenges we found is there isn’t a consistent definition of a premium cigar or other cigar types — a common definition is needed for future research,” Teutsch said. “Although premium cigars are not currently widely used, patterns of use could shift based on changes in price, marketing practices, or regulatory changes. Therefore, the research agenda recommended by the committee is needed to provide an understanding of premium cigar use, consumer awareness and perceptions, and health effects over time.”

Marketing and Risk Perceptions

Cigar lifestyle magazines, festivals, and social media sites have become popular forums for the tobacco industry to market premium cigars. Across these forums, the evidence is strongly suggestive that premium cigars are marketed as a product with benefits that outweigh their adverse health effects. Some content within lifestyle magazines implies the health effects of premium cigar use is lower compared to cigarette use, and that premium cigars are a safe substitution for cigarettes. Moreover, as social media platforms evolve, tobacco companies’ marketing practices will likely evolve, too. Future studies need to keep up with these changing trends, says the report, and research on consumer knowledge of premium cigars, including the definition and whether consumers distinguish premium cigars from other cigars, is needed.

Priority Research Areas

The FDA, in consultation with other federal agencies, should develop formal categories and definitions for cigars to be used for research to ensure consistency among studies. Using common definitions of cigar types, the FDA, the National Institutes of Health, and other federal agencies should support research on the health effects of premium cigars, compared to other large cigars, little cigars, or cigarillos. Research should also evaluate how various premium cigar characteristics (such as size, shape, type of tobacco, flavor, and moisture) affect puffing duration and volume.

The report also recommends the U.S. Department of Health and Human Services, in partnership with the Alcohol and Tobacco Tax and Trade Bureau and the Federal Trade Commission, develop surveillance and evaluation systems that regularly monitor patterns of cigar use, product characteristics, and consumer knowledge and perceptions by cigar type. These systems should also track exposure to cigar smoke and related health outcomes; monitor tobacco industry marketing and promotion strategies and sales; and track cigar prices by cigar type. In addition, the agency should ensure that the tobacco research it already supports, such as the Population Assessment of Tobacco and Health, surveys participants about premium cigar use.

The study — undertaken by the Committee on Patterns of Use and Health Effects of “Premium Cigars” and Priority Research — was sponsored by the U.S. Food and Drug Administration and the National Institutes of Health. The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide independent, objective analysis and advice to the nation to solve complex problems and inform public policy decisions related to science, technology, and medicine. They operate under an 1863 congressional charter to the National Academy of Sciences, signed by President Lincoln.

by Stephanie Miceli


The UCLA Fielding School of Public Health, founded in 1961, is dedicated to enhancing the public's health by conducting innovative research, training future leaders and health professionals from diverse backgrounds, translating research into policy and practice, and serving our local communities and the communities of the nation and the world. The school has 761 students from 26 nations engaged in carrying out the vision of building healthy futures in greater Los Angeles, California, the nation and the world.

Faculty Referenced by this Article

Faculty/staff profile placeholder image
Steven Teutsch
Health Policy and Management
Read Faculty Profile
Faculty/staff profile placeholder image
Ron Andersen

Dr. Ron Andersen is the Wasserman Professor Emeritus in the UCLA Departments of Health Policy and Management.

Health Policy and Management
Read Faculty Profile
Faculty/staff profile placeholder image
Julie A. Elginer

EMPH Academic Program Director with expertise in healthcare marketing, finance, and reproductive health policy, teaching in the EMPH, MPH, MHA program

Health Policy and Management
Read Faculty Profile
Aronberg, Sandra
Sandra Aronberg
Health Policy and Management
Read Faculty Profile
Sangeeta Ahluwalia
Sangeeta Ahluwalia
Health Policy and Management
Read Faculty Profile
Avram Kaplan
Avram Kaplan
Health Policy and Management
Read Faculty Profile
Dr. Thomas Rice
Thomas Rice
Health Policy and Management
Read Faculty Profile
Faculty/staff profile placeholder image
Barbara Berman
Health Policy and Management
Read Faculty Profile
Dr. Kristen Choi
Kristen Choi
Health Policy and Management
Read Faculty Profile
Dr. Alice Kuo
Alice Kuo
Health Policy and Management
Read Faculty Profile
Ron D. Hays
Ron D. Hays

@UCLA since 1997

Health Policy and Management
Read Faculty Profile
Faculty/staff profile placeholder image
Lori Pelliccioni
Health Policy and Management
Read Faculty Profile
Dr. Kenneth Wells
Kenneth Wells
Health Policy and Management
Read Faculty Profile
Isomi Miake-Lye
Isomi Miake-Lye
Health Policy and Management
Read Faculty Profile
Faculty/staff profile placeholder image
Robert Brook
Health Policy and Management
Read Faculty Profile
Freund, Deborah
Deborah Anne Freund
Health Policy and Management
Read Faculty Profile
Faculty/staff profile placeholder image
Annette Maxwell
Health Policy and Management
Read Faculty Profile
Faculty/staff profile placeholder image
Alan Tomines
Health Policy and Management
Read Faculty Profile
Robert Kaplan
Robert Kaplan
Health Policy and Management
Read Faculty Profile
Leah Vriesman
Leah Vriesman
Health Policy and Management
Read Faculty Profile
Dr. Joann Elmore
Joann G. Elmore
Health Policy and Management
Read Faculty Profile
Dr. Frederick Zimmerman
Frederick Zimmerman
Health Policy and Management
Read Faculty Profile
Yusuke Tsugawa
Yusuke Tsugawa
Health Policy and Management
Read Faculty Profile
Diana Hilberman
Diana Hilberman
Health Policy and Management
Read Faculty Profile
Dr. Anthony Schiff
Anthony Hunter Schiff
Health Policy and Management
Read Faculty Profile
Galper, Michael
Michael Galper
Health Policy and Management
Read Faculty Profile
Dr. Beth Glenn
Beth Glenn
Health Policy and Management
Read Faculty Profile
Michelle Keller
Michelle S. Keller

Dr. Michelle S. Keller is a health services researcher whose research focuses on the use and prescribing of high-risk medications.

Health Policy and Management
Read Faculty Profile
Faculty/staff profile placeholder image
Brennan Spiegel
Health Policy and Management
Read Faculty Profile
Faculty/staff profile placeholder image
Thomas Priselac
Health Policy and Management
Read Faculty Profile
Dr. Paul Fu, Jr.
Paul Fu, Jr.
Health Policy and Management
Read Faculty Profile
Dr. William McCarthy
William J. McCarthy
Health Policy and Management
Read Faculty Profile
Clifford Ko
Clifford Ko
Health Policy and Management
Read Faculty Profile
Rosenstock
Linda Rosenstock
Environmental Health Sciences Health Policy and Management
Read Faculty Profile
Dr. Risha Gidwani
Risha Gidwani
Health Policy and Management
Read Faculty Profile
Faculty/staff profile placeholder image
Neal Halfon
Health Policy and Management
Read Faculty Profile
Comanor, Bill
William Comanor
Health Policy and Management
Read Faculty Profile
Dr. Elizabeth (Becky) Yano
Elizabeth (Becky) Yano
Health Policy and Management
Read Faculty Profile
Image of Dr. Susan Ettner
Susan Ettner
Health Policy and Management
Read Faculty Profile
Moira Inkelas
Moira Inkelas
Health Policy and Management
Read Faculty Profile
Patricia Ganz
Patricia Ganz
Health Policy and Management
Read Faculty Profile
Laura Erskine
Laura Erskine
Health Policy and Management
Read Faculty Profile
Dr. Dylan Roby
Dylan Roby
Health Policy and Management
Read Faculty Profile
silhoette
Ty Robbins
Health Policy and Management
Read Faculty Profile
Vickie Mays
Vickie Mays
Health Policy and Management
Read Faculty Profile
Warren Scott Comulada
Warren Scott Comulada
Health Policy and Management
Read Faculty Profile
Faculty/staff profile placeholder image
Arlene Fink
Health Policy and Management
Read Faculty Profile
Jack Needleman
Jack Needleman
Health Policy and Management
Read Faculty Profile
Dr. Jonathan Fielding
Jonathan Fielding
Health Policy and Management
Read Faculty Profile
Jody Heymann
Jody Heymann
Epidemiology Health Policy and Management
Read Faculty Profile
Balgrosky headshot
Jean Balgrosky
Health Policy and Management
Read Faculty Profile
Dr. Arturo Vargas Bustamante
Arturo Vargas Bustamante
Health Policy and Management
Read Faculty Profile
Dr. Jennifer Wortham
Jennifer Wortham
Health Policy and Management
Read Faculty Profile
Paul Chung
Paul Chung
Health Policy and Management
Read Faculty Profile
Gerald Kominski
Gerald Kominski
Health Policy and Management
Read Faculty Profile
Dr. Aria Fallah
Aria Fallah
Health Policy and Management
Read Faculty Profile
Faculty/staff profile placeholder image
Mark Litwin
Health Policy and Management
Read Faculty Profile
Mangione, C
Carol Mangione
Health Policy and Management
Read Faculty Profile
Kadiyala, Srikanth
Srikanth Kadiyala
Health Policy and Management
Read Faculty Profile
Dr. Samuel Sessions
Samuel Sessions
Health Policy and Management
Read Faculty Profile
Nadereh Pourat
Nadereh Pourat
Health Policy and Management
Read Faculty Profile
Davidson - headshop
Pamela Davidson
Health Policy and Management
Read Faculty Profile
Jeanne Miranda
Jeanne Miranda
Health Policy and Management
Read Faculty Profile
Dr. Naomi Zewde
Naomi Zewde
Health Policy and Management
Read Faculty Profile
Dr. Felicia Hodge
Felicia Hodge
Health Policy and Management
Read Faculty Profile
Gordon headshot
Thomas D. Gordon
Health Policy and Management
Read Faculty Profile
Dr. Stephanie Taylor
Stephanie L. Taylor

Nationally recognized health services researcher and sociomedical scientist with 25+ years' experience in effectiveness and implementation research.

Health Policy and Management
Read Faculty Profile
Faculty/staff profile placeholder image
Emmeline Chuang
Health Policy and Management
Read Faculty Profile
Burt Cowgill
Burt Cowgill
Health Policy and Management
Read Faculty Profile
James Macinko
James Macinko

Professor of Community Health Sciences & Health Policy and Management, and Associate Dean for Research

Community Health Sciences Health Policy and Management
Read Faculty Profile
Dr. Yvonne Flores
Yvonne Flores
Health Policy and Management
Read Faculty Profile
Faculty/staff profile placeholder image
David Hayes-Bautista
Health Policy and Management
Read Faculty Profile
Michael Ong
Michael Ong
Health Policy and Management
Read Faculty Profile
Corrina Moucheraud
Corrina Moucheraud
Health Policy and Management
Read Faculty Profile
Dr. Xi Zhu
Xi Zhu
Health Policy and Management
Read Faculty Profile
Faculty/staff profile placeholder image
Jose J. Escarce
Health Policy and Management
Read Faculty Profile
Dr. Lillian Gelberg
Lillian Gelberg
Health Policy and Management
Read Faculty Profile
Dr. Daniel Eisenberg
Daniel Eisenberg
Health Policy and Management
Read Faculty Profile
Roshan Bastani Headshot
Roshan Bastani
Health Policy and Management
Read Faculty Profile
Dr. Ninez Ponce
Ninez Ponce
Health Policy and Management
Read Faculty Profile
Emily Abel
Emily Abel
Health Policy and Management
Read Faculty Profile
Olivia Jung
Olivia Jung
Health Policy and Management
Read Faculty Profile
Dr. John Lu
Z. John Lu
Health Policy and Management
Read Faculty Profile

Related Content

CHPR_2024_firearms_suiciderisk_thumbnail
April 30, 2024
Access to firearms for Californians aged 15–24 associated with increased suicide risk
Source: UCLA Center for Health Policy Research Read Full Article
Dr._Ying-Ying_Meng
April 16, 2024
In memoriam: Dr. Ying-Ying Meng, 68, scholar of environmental health and director of research at the UCLA Center for Health Policy Research
Source: UCLA Center for Health Policy Research Read Full Article